Group of leading academics say Humira patent thicketing antitrust issues must be looked at again
Professors seek reversal of original district court decision, following the dismissal of a potential landmark dispute over the nature of sham litigation
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.